SB 939
-
Catalog number2285-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name3-[2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl]-N-hydroxy-2E-propenamide; Pracinostat
-
DescriptionAn orally available pan-histone deacetylase (HDAC) inhibitor binding all HDAC isozymes with similar affinity (Kis = 16-28 nM) with the exception of HDAC6 and 7 (Kis = 247 and 104 nM, respectively). SB 939 demonstrates good bioavailability in vivo and significantly inhibits tumor growth in various xenograft mouse models at doses ranging from 25-100 mg/kg.
-
CAS Number929016-96-6
-
Structure AvailableYes
-
Peptide sequenceNo
-
Salt FormNo
-
Molecular FormulaC₂₀H₃₀N₄O₂
-
Molecular Weight358.48
-
Cell PermeableYes
-
Purity≥98%
-
SolubilitiesDMSO
-
HandlingProtect from light and moisture
-
Tag LineA pan-HDAC inhibitor
-
Storage Condition-20 ̊C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID49855250
-
SMILESCCCCC1=NC2=C(N1CCN(CC)CC)C=CC(=C2)C=CC(=O)NO
-
InChiInChI=1S/C20H30N4O2/c1-4-7-8-19-21-17-15-16(10-12-20(25)22-26)9-11-18(17)24(19)14-13-23(5-2)6-3/h9-12,15,26H,4-8,13-14H2,1-3H3,(H,22,25)/b12-10+
-
InChi KeyJHDKZFFAIZKUCU-ZRDIBKRKSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameSB 939
-
Alternative nameSB 939
-